9 Meters Biopharma (NMTRQ) Stock Statistics & Valuation Metrics

9 Meters Biopharma has a market cap or net worth of $14.00. The enterprise value is ―.

9 Meters Biopharma has 14,459,690 shares outstanding. The number of shares has decreased by -2.65% in one year.

9 Meters Biopharma’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of 9 Meters Biopharma is ―. 9 Meters Biopharma’s PEG ratio is ―.

In the last 12 months, 9 Meters Biopharma had revenue of ― and earned -43.77M in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

9 Meters Biopharma pays an annual dividend of ―, resulting in a dividend yield of ―

9 Meters Biopharma upcoming earnings date is May 14, 2024, TBA (Confirmed).

9 Meters Biopharma as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, 9 Meters Biopharma has paid ― in taxes.

9 Meters Biopharma EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

9 Meters Biopharma has ― in cash and marketable securities with 5.17M in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for 9 Meters Biopharma is ―, which is 11.43% higher than the current price. The consensus rating is ―